

Part 1
Part 2
Part 3
Part 5
Description
Long-acting Reversible Contraceptives (LARCs) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Long-acting Reversible Contraceptives (LARCs) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Age 20-24 and Age 25-34 are the major drivers for the industry. North America, Europe and Asia Pacific are the key regions for Long-acting Reversible Contraceptives (LARCs) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Long-acting Reversible Contraceptives (LARCs) key manufacturers include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc. Bayer, Merck, Cooper Companies are top 3 players and held % sales share in total in 2022. Long-acting Reversible Contraceptives (LARCs) can be divided into Hormonal Intrauterine Devices, Copper Intrauterine Devices, Contraceptive Implants and Others, etc. Hormonal Intrauterine Devices is the mainstream product in the market, accounting for % sales share globally in 2022. Long-acting Reversible Contraceptives (LARCs) is widely used in various fields, such as Age 20-24, Age 25-34, Age 35-44 and Others, etc. Age 20-24 provides greatest supports to the Long-acting Reversible Contraceptives (LARCs) industry development. In 2022, global % sales of Long-acting Reversible Contraceptives (LARCs) went into Age 20-24 filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Long-acting Reversible Contraceptives (LARCs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Bayer Merck Cooper Companies AbbVie Allergan Yantai JiShengYaoXie H & J Medical HRA Pharma Pregna ASPIVIX Shanghai Dahua Pharmaceuticals Williams Medical Supplies Laboratoire 7 MED Durbin Laboratoire CCD Prosan OCON Segment by Type Hormonal Intrauterine Devices Copper Intrauterine Devices Contraceptive Implants Others Segment by Application Age 20-24 Age 25-34 Age 35-44 Others Segment by Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Each chapter of the report provides detailed information for readers to understand the Long-acting Reversible Contraceptives (LARCs) market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Long-acting Reversible Contraceptives (LARCs), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Long-acting Reversible Contraceptives (LARCs) industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Long-acting Reversible Contraceptives (LARCs) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Long-acting Reversible Contraceptives (LARCs) introduction, etc. Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Long-acting Reversible Contraceptives (LARCs) market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
Table of Contents
1 Long-acting Reversible Contraceptives (LARCs) Market Overview
1.1 Long-acting Reversible Contraceptives (LARCs) Product Overview
1.2 Long-acting Reversible Contraceptives (LARCs) Market Segment by Type
1.2.1 Hormonal Intrauterine Devices
1.2.2 Copper Intrauterine Devices
1.2.3 Contraceptive Implants
1.2.4 Others
1.3 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Type
1.3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Type (2018-2029)
1.3.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Type (2018-2023)2 Global Long-acting Reversible Contraceptives (LARCs) Market Competition by Company
2.1 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Sales (2018-2023)
2.2 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Revenue (2018-2023)
2.3 Global Top Players by Long-acting Reversible Contraceptives (LARCs) Price (2018-2023)
2.4 Global Top Manufacturers Long-acting Reversible Contraceptives (LARCs) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Long-acting Reversible Contraceptives (LARCs) Market Competitive Situation and Trends
2.5.1 Long-acting Reversible Contraceptives (LARCs) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Long-acting Reversible Contraceptives (LARCs) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-acting Reversible Contraceptives (LARCs) as of 2022)
2.7 Date of Key Manufacturers Enter into Long-acting Reversible Contraceptives (LARCs) Market
2.8 Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Offered
2.9 Mergers & Acquisitions, Expansion3 Long-acting Reversible Contraceptives (LARCs) Status and Outlook by Region
3.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Region
3.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2018-2023)
3.2.2 Global Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2018-2023)
3.2.3 Global Long-acting Reversible Contraceptives (LARCs) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Region
3.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2024-2029)
3.3.2 Global Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2024-2029)
3.3.3 Global Long-acting Reversible Contraceptives (LARCs) Sales (Volume & Value), Price and Gross Margin (2024-2029)4 Global Long-acting Reversible Contraceptives (LARCs) by Application
4.1 Long-acting Reversible Contraceptives (LARCs) Market Segment by Application
4.1.1 Age 20-24
4.1.2 Age 25-34
4.1.3 Age 35-44
4.1.4 Others
4.2 Global Long-acting Reversible Contraceptives (LARCs) Market Size by Application
4.2.1 Global Long-acting Reversible Contraceptives (LARCs) Market Size Overview by Application (2018-2029)
4.2.2 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Breakdown by Application (2018-2023)5 North America Long-acting Reversible Contraceptives (LARCs) by Country
5.1 North America Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Country
5.1.1 North America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2018-2023)
5.1.3 North America Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2018-2023)
5.2 North America Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Country
5.2.1 North America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2024-2029)
5.2.2 North America Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2024-2029)6 Europe Long-acting Reversible Contraceptives (LARCs) by Country
6.1 Europe Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Country
6.1.1 Europe Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2018-2023)
6.1.3 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2018-2023)
6.2 Europe Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Country
6.2.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2024-2029)
6.2.2 Europe Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2024-2029)7 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) by Region
7.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Region
7.1.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Region
7.2.1 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales in Value by Region (2024-2029)8 Latin America Long-acting Reversible Contraceptives (LARCs) by Country
8.1 Latin America Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Country
8.1.1 Latin America Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2018-2023)
8.2 Latin America Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Country
8.2.1 Latin America Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2024-2029)9 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) by Country
9.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Historic Market Size by Country
9.1.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Forecasted Market Size by Country
9.2.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales in Value by Country (2024-2029)10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Products Offered
10.1.5 Bayer Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Products Offered
10.2.5 Merck Recent Development
10.3 Cooper Companies
10.3.1 Cooper Companies Company Information
10.3.2 Cooper Companies Introduction and Business Overview
10.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Products Offered
10.3.5 Cooper Companies Recent Development
10.4 AbbVie Allergan
10.4.1 AbbVie Allergan Company Information
10.4.2 AbbVie Allergan Introduction and Business Overview
10.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Products Offered
10.4.5 AbbVie Allergan Recent Development
10.5 Yantai JiShengYaoXie
10.5.1 Yantai JiShengYaoXie Company Information
10.5.2 Yantai JiShengYaoXie Introduction and Business Overview
10.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Products Offered
10.5.5 Yantai JiShengYaoXie Recent Development
10.6 H & J Medical
10.6.1 H & J Medical Company Information
10.6.2 H & J Medical Introduction and Business Overview
10.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Products Offered
10.6.5 H & J Medical Recent Development
10.7 HRA Pharma
10.7.1 HRA Pharma Company Information
10.7.2 HRA Pharma Introduction and Business Overview
10.7.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Products Offered
10.7.5 HRA Pharma Recent Development
10.8 Pregna
10.8.1 Pregna Company Information
10.8.2 Pregna Introduction and Business Overview
10.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Products Offered
10.8.5 Pregna Recent Development
10.9 ASPIVIX
10.9.1 ASPIVIX Company Information
10.9.2 ASPIVIX Introduction and Business Overview
10.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Products Offered
10.9.5 ASPIVIX Recent Development
10.10 Shanghai Dahua Pharmaceuticals
10.10.1 Shanghai Dahua Pharmaceuticals Company Information
10.10.2 Shanghai Dahua Pharmaceuticals Introduction and Business Overview
10.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Products Offered
10.10.5 Shanghai Dahua Pharmaceuticals Recent Development
10.11 Williams Medical Supplies
10.11.1 Williams Medical Supplies Company Information
10.11.2 Williams Medical Supplies Introduction and Business Overview
10.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Products Offered
10.11.5 Williams Medical Supplies Recent Development
10.12 Laboratoire 7 MED
10.12.1 Laboratoire 7 MED Company Information
10.12.2 Laboratoire 7 MED Introduction and Business Overview
10.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Products Offered
10.12.5 Laboratoire 7 MED Recent Development
10.13 Durbin
10.13.1 Durbin Company Information
10.13.2 Durbin Introduction and Business Overview
10.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Products Offered
10.13.5 Durbin Recent Development
10.14 Laboratoire CCD
10.14.1 Laboratoire CCD Company Information
10.14.2 Laboratoire CCD Introduction and Business Overview
10.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Products Offered
10.14.5 Laboratoire CCD Recent Development
10.15 Prosan
10.15.1 Prosan Company Information
10.15.2 Prosan Introduction and Business Overview
10.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Products Offered
10.15.5 Prosan Recent Development
10.16 OCON
10.16.1 OCON Company Information
10.16.2 OCON Introduction and Business Overview
10.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2018-2023)
10.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Products Offered
10.16.5 OCON Recent Development11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Long-acting Reversible Contraceptives (LARCs) Industrial Chain Analysis
11.4 Long-acting Reversible Contraceptives (LARCs) Market Dynamics
11.4.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
11.4.2 Long-acting Reversible Contraceptives (LARCs) Market Drivers
11.4.3 Long-acting Reversible Contraceptives (LARCs) Market Challenges
11.4.4 Long-acting Reversible Contraceptives (LARCs) Market Restraints12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Long-acting Reversible Contraceptives (LARCs) Distributors
12.3 Long-acting Reversible Contraceptives (LARCs) Downstream Customers13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Major Company of Hormonal Intrauterine Devices
Table 2. Major Company of Copper Intrauterine Devices
Table 3. Major Company of Contraceptive Implants
Table 4. Major Company of Others
Table 5. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (K Units)
Table 7. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type (2018-2023)
Table 8. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US& Million)
Table 9. Global Long-acting Reversible Contraceptives (LARCs) Market Share in Value by Type (2018-2023)
Table 10. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2024-2029) & (K Units)
Table 12. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type (2024-2029)
Table 15. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (K Units)
Table 17. North America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
Table 18. Europe Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2018-2023)
Table 19. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
Table 20. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2018-2023)
Table 21. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
Table 22. Latin America Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2018-2023)
Table 23. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
Table 24. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Type (2018-2023)
Table 25. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2023) & (US$ Million)
Table 26. Global Long-acting Reversible Contraceptives (LARCs) Sales by Company (2018-2023) & (K Units)
Table 27. Global Long-acting Reversible Contraceptives (LARCs) Sales Share by Company (2018-2023)
Table 28. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Company (2018-2023) & (US$ Million)
Table 29. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Company (2018-2023)
Table 30. Global Market Long-acting Reversible Contraceptives (LARCs) Price by Company (2018-2023) & (US$/Unit)
Table 31. Global Long-acting Reversible Contraceptives (LARCs) Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Long-acting Reversible Contraceptives (LARCs) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Long-acting Reversible Contraceptives (LARCs) as of 2022)
Table 34. Date of Key Manufacturers Enter into Long-acting Reversible Contraceptives (LARCs) Market
Table 35. Key Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Long-acting Reversible Contraceptives (LARCs) Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2018-2023) & (K Units)
Table 39. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2018-2023)
Table 40. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2018-2023) & (US$ Million)
Table 41. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2018-2023)
Table 42. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 43. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2024-2029) & (K Units)
Table 44. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2024-2029)
Table 47. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (K Units)
Table 50. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application (2018-2023)
Table 51. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
Table 52. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application (2018-2023)
Table 53. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2018-2023) & (US$/Unit)
Table 54. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2024-2029) & (K Units)
Table 55. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application (2024-2029)
Table 58. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units)
Table 60. North America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
Table 61. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units)
Table 62. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
Table 63. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units)
Table 64. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
Table 65. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units)
Table 66. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) (K Units)
Table 68. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2023) & (US$ Million)
Table 69. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (K Units)
Table 70. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2018-2023)
Table 71. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (US$ Million)
Table 72. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2018-2023)
Table 73. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (K Units)
Table 74. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (K Units)
Table 78. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2018-2023)
Table 79. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (US$ Million)
Table 80. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2018-2023)
Table 81. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (K Units)
Table 82. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2018-2023)
Table 87. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2018-2023) & (US$ Million)
Table 88. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2018-2023)
Table 89. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (K Units)
Table 94. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2018-2023)
Table 95. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (US$ Million)
Table 96. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2018-2023)
Table 97. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (K Units)
Table 102. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2018-2023)
Table 103. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2018-2023) & (US$ Million)
Table 104. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2018-2023)
Table 105. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Country (2024-2029)
Table 109. Bayer Company Information
Table 110. Bayer Introduction and Business Overview
Table 111. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Bayer Long-acting Reversible Contraceptives (LARCs) Product
Table 113. Bayer Recent Development
Table 114. Merck Company Information
Table 115. Merck Introduction and Business Overview
Table 116. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Merck Long-acting Reversible Contraceptives (LARCs) Product
Table 118. Merck Recent Development
Table 119. Cooper Companies Company Information
Table 120. Cooper Companies Introduction and Business Overview
Table 121. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 122. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product
Table 123. Cooper Companies Recent Development
Table 124. AbbVie Allergan Company Information
Table 125. AbbVie Allergan Introduction and Business Overview
Table 126. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 127. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product
Table 128. AbbVie Allergan Recent Development
Table 129. Yantai JiShengYaoXie Company Information
Table 130. Yantai JiShengYaoXie Introduction and Business Overview
Table 131. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 132. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product
Table 133. Yantai JiShengYaoXie Recent Development
Table 134. H & J Medical Company Information
Table 135. H & J Medical Introduction and Business Overview
Table 136. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 137. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product
Table 138. H & J Medical Recent Development
Table 139. HRA Pharma Company Information
Table 140. HRA Pharma Introduction and Business Overview
Table 141. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 142. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product
Table 143. HRA Pharma Recent Development
Table 144. Pregna Company Information
Table 145. Pregna Introduction and Business Overview
Table 146. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 147. Pregna Long-acting Reversible Contraceptives (LARCs) Product
Table 148. Pregna Recent Development
Table 149. ASPIVIX Company Information
Table 150. ASPIVIX Introduction and Business Overview
Table 151. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 152. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product
Table 153. ASPIVIX Recent Development
Table 154. Shanghai Dahua Pharmaceuticals Company Information
Table 155. Shanghai Dahua Pharmaceuticals Introduction and Business Overview
Table 156. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 157. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product
Table 158. Shanghai Dahua Pharmaceuticals Recent Development
Table 159. Williams Medical Supplies Company Information
Table 160. Williams Medical Supplies Introduction and Business Overview
Table 161. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 162. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product
Table 163. Williams Medical Supplies Recent Development
Table 164. Laboratoire 7 MED Company Information
Table 165. Laboratoire 7 MED Introduction and Business Overview
Table 166. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 167. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product
Table 168. Laboratoire 7 MED Recent Development
Table 169. Durbin Company Information
Table 170. Durbin Introduction and Business Overview
Table 171. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 172. Durbin Long-acting Reversible Contraceptives (LARCs) Product
Table 173. Durbin Recent Development
Table 174. Laboratoire CCD Company Information
Table 175. Laboratoire CCD Introduction and Business Overview
Table 176. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 177. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product
Table 178. Laboratoire CCD Recent Development
Table 179. Prosan Company Information
Table 180. Prosan Introduction and Business Overview
Table 181. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 182. Prosan Long-acting Reversible Contraceptives (LARCs) Product
Table 183. Prosan Recent Development
Table 184. OCON Company Information
Table 185. OCON Introduction and Business Overview
Table 186. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 187. OCON Long-acting Reversible Contraceptives (LARCs) Product
Table 188. OCON Recent Development
Table 189. Key Raw Materials Lists
Table 190. Raw Materials Key Suppliers Lists
Table 191. Long-acting Reversible Contraceptives (LARCs) Market Trends
Table 192. Long-acting Reversible Contraceptives (LARCs) Market Drivers
Table 193. Long-acting Reversible Contraceptives (LARCs) Market Challenges
Table 194. Long-acting Reversible Contraceptives (LARCs) Market Restraints
Table 195. Long-acting Reversible Contraceptives (LARCs) Distributors List
Table 196. Long-acting Reversible Contraceptives (LARCs) Downstream Customers
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Long-acting Reversible Contraceptives (LARCs) Product Picture
Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Long-acting Reversible Contraceptives (LARCs) Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Long-acting Reversible Contraceptives (LARCs) Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Hormonal Intrauterine Devices
Figure 6. Global Hormonal Intrauterine Devices Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Copper Intrauterine Devices
Figure 8. Global Copper Intrauterine Devices Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Contraceptive Implants
Figure 10. Global Contraceptive Implants Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type in 2022 & 2029
Figure 15. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
Figure 16. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
Figure 17. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
Figure 18. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
Figure 21. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-acting Reversible Contraceptives (LARCs) Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-acting Reversible Contraceptives (LARCs) Revenue in 2022
Figure 27. Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Age 20-24
Figure 29. Global Age 20-24 Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Age 25-34
Figure 31. Global Age 25-34 Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Age 35-44
Figure 33. Global Age 35-44 Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Long-acting Reversible Contraceptives (LARCs) Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application in 2022 & 2029
Figure 38. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2022
Figure 39. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
Figure 40. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2022
Figure 41. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
Figure 44. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Long-acting Reversible Contraceptives (LARCs) Manufacturing Cost Structure
Figure 49. Long-acting Reversible Contraceptives (LARCs) Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Description
Long-acting Reversible Contraceptives (LARCs) report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Long-acting Reversible Contraceptives (LARCs) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Age 20-24 and Age 25-34 are the major drivers for the industry. North America, Europe and Asia Pacific are the key regions for Long-acting Reversible Contraceptives (LARCs) industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Long-acting Reversible Contraceptives (LARCs) key manufacturers include Bayer, Merck, Cooper Companies, AbbVie Allergan, Yantai JiShengYaoXie, H & J Medical, HRA Pharma, Pregna and ASPIVIX, etc. Bayer, Merck, Cooper Companies are top 3 players and held % sales share in total in 2022. Long-acting Reversible Contraceptives (LARCs) can be divided into Hormonal Intrauterine Devices, Copper Intrauterine Devices, Contraceptive Implants and Others, etc. Hormonal Intrauterine Devices is the mainstream product in the market, accounting for % sales share globally in 2022. Long-acting Reversible Contraceptives (LARCs) is widely used in various fields, such as Age 20-24, Age 25-34, Age 35-44 and Others, etc. Age 20-24 provides greatest supports to the Long-acting Reversible Contraceptives (LARCs) industry development. In 2022, global % sales of Long-acting Reversible Contraceptives (LARCs) went into Age 20-24 filed. Report Scope This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Long-acting Reversible Contraceptives (LARCs) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making. Manufacturers, Type, Application and Regions Listed in the Report: By Company Bayer Merck Cooper Companies AbbVie Allergan Yantai JiShengYaoXie H & J Medical HRA Pharma Pregna ASPIVIX Shanghai Dahua Pharmaceuticals Williams Medical Supplies Laboratoire 7 MED Durbin Laboratoire CCD Prosan OCON Segment by Type Hormonal Intrauterine Devices Copper Intrauterine Devices Contraceptive Implants Others Segment by Application Age 20-24 Age 25-34 Age 35-44 Others Segment by Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia U.A.E Each chapter of the report provides detailed information for readers to understand the Long-acting Reversible Contraceptives (LARCs) market further: Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Long-acting Reversible Contraceptives (LARCs), product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Long-acting Reversible Contraceptives (LARCs) industry. Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Long-acting Reversible Contraceptives (LARCs) in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023. Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis. Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Long-acting Reversible Contraceptives (LARCs) introduction, etc. Long-acting Reversible Contraceptives (LARCs) Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part. Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter. Chapter 12: Market Channel, Distributors and Customers are listed. Chapter 13: QYResearch’s Conclusions of Long-acting Reversible Contraceptives (LARCs) market based on comprehensive survey. Chapter 14: Methodology and Data Sources adopted by QYResearch.
USD 3350.00
USD 5025.00
USD 6700.00
Add to Cart
Buy Now
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 18 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Add to Cart
Buy Now